Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04146038
Title	Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
Recruitment	Completed
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Rutgers, The State University of New Jersey
Indications	myelodysplastic syndrome chronic myelomonocytic leukemia acute myeloid leukemia myeloproliferative neoplasm
Therapies	Decitabine + Salsalate + Venetoclax Azacitidine + Salsalate + Venetoclax
Age Groups:	adult \| senior
Covered Countries	USA